Detalhe da pesquisa
1.
Contribution of collegial support meetings (CSM) in the management of complex situations of patients with advanced cancer.
Support Care Cancer
; 31(6): 329, 2023 May 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37154941
2.
PD-1 blockade induces responses by inhibiting adaptive immune resistance.
Nature
; 515(7528): 568-71, 2014 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-25428505
3.
Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.
J Hepatol
; 68(6): 1181-1190, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-29427729
4.
Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med
; 372(26): 2521-32, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891173
5.
Older melanoma patients aged 75 and above retain responsiveness to anti-PD1 therapy: results of a retrospective single-institution cohort study.
Cancer Immunol Immunother
; 67(10): 1571-1578, 2018 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-30056599
6.
Renal effects of immune checkpoint inhibitors.
Nephrol Dial Transplant
; 32(6): 936-942, 2017 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28025384
7.
Blue Lymphangitis of the Breast after Breast Cancer: Case Report.
Breast J
; 23(3): 348-351, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-27914118
8.
Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma.
N Engl J Med
; 369(2): 134-44, 2013 Jul 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-23724846
9.
Association of Pembrolizumab With Tumor Response and Survival Among Patients With Advanced Melanoma.
JAMA
; 315(15): 1600-9, 2016 Apr 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-27092830
10.
Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial.
Lancet
; 384(9948): 1109-17, 2014 Sep 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-25034862
11.
Correlation of phenotype/genotype in a cohort of 23 xeroderma pigmentosum-variant patients reveals 12 new disease-causing POLH mutations.
Hum Mutat
; 35(1): 117-28, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24130121
12.
Drug-induced lupus erythematosus following immunotherapy with anti-programmed death-(ligand) 1.
Ann Rheum Dis
; 78(7): e67, 2019 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29858173
13.
Kidney injuries related to ipilimumab.
Invest New Drugs
; 32(4): 769-73, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24687600
14.
Melanoma arising from a long-standing pigmented trichoblastoma: clinicopathologic study with complementary aCGH/mutational analysis.
Am J Dermatopathol
; 36(8): e146-51, 2014 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-24335517
15.
[PAL-PRAT study: Healthcare workers' knowledge and perception of palliative practices in a Cancer Center]. / Quelle connaissance et quelle perception ont les professionnels de santé d'un Centre de lutte contre le cancer à propos des pratiques palliatives encadrées par la loi Claeys-Leonetti : étude PAL PRAT.
Bull Cancer
; 111(6): 554-565, 2024 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-38458927
16.
Legalisation of euthanasia and assisted suicide: advanced cancer patient opinions - cross-sectional multicentre study.
BMJ Support Palliat Care
; 13(e3): e1335-e1341, 2024 Jan 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37536753
17.
[End of life and cancer: Understanding the ethical issues of voluntary assisted dying]. / Fin de vie et cancer : comprendre en 2023 les enjeux de la demande d'aide active à mourir.
Bull Cancer
; 110(3): 293-300, 2023 Mar.
Artigo
em Francês
| MEDLINE | ID: mdl-36746703
18.
[Implementation of a multimodal strategy for information and collection of advance directives in a comprehensive cancer center]. / Mise en place d'une stratégie multimodale d'information et de recueil des directives anticipées dans un Centre de lutte contre le cancer (CLCC).
Bull Cancer
; 110(6): 635-645, 2023 Jun.
Artigo
em Francês
| MEDLINE | ID: mdl-36963998
19.
Severe meningo-radiculo-neuritis associated with ipilimumab.
Invest New Drugs
; 30(6): 2407-10, 2012 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-22231551
20.
Acute Lower Limb Ischaemia and Diabetes in a Patient Treated with Anti-PD1 Monoclonal Antibody for Metastatic Melanoma.
Acta Derm Venereol
; 97(3): 408-409, 2017 03 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27377178